Edimer Pharmaceuticals
Cambridge, Massachusetts, 02142, United States
NCT Number: NCT01398397
This study is being done to collect information about people who have or may have Hypohidrotic Ectodermal Dysplasia (HED) or X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). This study will allow Edimer Pharmaceuticals to know more about HED/XLHED so that hopefully the investigators can develop a drug to treat this condition. In this study Edimer will retrospectively review and abstract (summarize) medical records of people that have or may have HED/XLHED in order to further understand the natural history and disease characteristics.
Looking for future studies?
Notify MeAll sexes
Observational
Cambridge, Massachusetts, 02142, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-Males or females with:
-OR-
Edimer Pharmaceuticals
Industry
Acronym: ECP-006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01398813
Abnormalities, Multiple, Congenital Abnormalities
Portland, Maine, United States
View Trial DetailsNCT01629940
Abnormalities, Multiple, Congenital Abnormalities
Orlando, Florida, United States
View Trial DetailsNCT01629927
Abnormalities, Multiple, Congenital Abnormalities
Burgos, Spain
View Trial DetailsNCT05378932
Abnormalities, Multiple, Congenital Abnormalities
Paris, France
View Trial Details